Stockreport

Cyclo Therapeutics Presents Positive Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label Sub-Study in Patients (< 3 Years Old) [Yahoo! Finance]

Cyclo Therapeutics, Inc.  (CYTH) 
PDF Business Wire Fri, February 7, 2025 at 2:05 PM GMT+1 8 min read In This Article CYTH CYTHW First data in NPC1 on treatment in this age group over a period o [Read more]